A study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has identified an abnormal metabolic pathway that drives cancer-cell growth in a particular glioblastoma subtype.
http://www.eurekalert.org/pub_releases/2013-06/osum-mmd061313.php
http://www.eurekalert.org/pub_releases/2013-06/osum-mmd061313.php
No comments:
Post a Comment